A new, affordable cloud-based Hospital Management Information System, e-Sushrut clinic, is set to launch for small healthcare facilities. D...

Indian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...

At present, more than three-quarters (76%) of India’s population is at high or very high risk of extreme heat.

The Indian Embassy in Doha has confirmed the return of mortal remains for eight Indian nationals who tragically lost their lives in the Ras...

The World Health Organisation (WHO) has sought details from the Indian government after reports linked oxytocin injections made by Jackson ...

India's drug regulator is intensifying border screenings to block unapproved medicines from entering the country. Authorities are cracking ...

Indian pharmaceutical giant Zydus Lifesciences has partnered with Sri Lanka's Sunshine Healthcare Lanka to establish a new manufacturing fa...

India is set to implement a mandatory registration for printed pharmaceutical packaging manufacturers to combat counterfeit drugs. This mov...

The National Highways Authority of India is intensifying efforts to clear illegal parking and roadside encroachments on national highways, ...

Indian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...

Niti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think ta...

India's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearl...

Government's Minimum Import Price (MIP) initiative to boost domestic drug makers faces a slow start. Despite setting price thresholds for k...

The US has launched a trade probe into Germany's pharmaceutical pricing, alleging it unfairly burdens American commerce and forces the US t...

Prices for active pharmaceutical ingredients have seen a decline of five to ten percent, thanks to the calming geopolitical climate in West...

India's drug price regulator has increased the ceiling prices of cancer drugs cisplatin and carboplatin by 50% to tackle shortages caused b...

India's drug pricing authority has approved a 50% price hike for essential anti-cancer drugs carboplatin and cisplatin. This decision follo...